Vimarsana
Biggest News Aggregation in the World

Page 37 - Twist Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Twist Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Twist Bioscience Today - Breaking & Trending Today

Twist Bioscience to Present at ITF World 2023 - Vimarsana News

Twist Bioscience to Present at ITF World 2023

Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D.,... | May 10, 2023

Twist Bioscience Corporation: Twist Bioscience to Present at ITF World 2023 - Vimarsana News

Twist Bioscience Corporation: Twist Bioscience to Present at ITF World 2023

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust

Spring 2023 Layoff Tracker: Akamai Technologies Cuts Hundreds Of Employees, Report Says - Vimarsana News

Spring 2023 Layoff Tracker: Akamai Technologies Cuts Hundreds Of Employees, Report Says

Internet and cybersecurity company Akamai Technologies announced plans this week to cut nearly 300 employees, while biotech startup Twist Bioscience plans to…

Source: biztoc.com
Taysha Gene Therapies (NASDAQ:TSHA) versus Twist Bioscience (NASDAQ:TWST) Head to Head Analysis - Vimarsana News

Taysha Gene Therapies (NASDAQ:TSHA) versus Twist Bioscience (NASDAQ:TWST) Head to Head Analysis

Taysha Gene Therapies (NASDAQ:TSHA – Get Rating) and Twist Bioscience (NASDAQ:TWST – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Profitability This table compares Taysha Gene Therapies and […]

Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results - Vimarsana News

Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results

– Record revenue of $60.2M in 2QFY23; up 25% over $48.1M in 2QFY22 – – Orders increased to $64.2M in 2QFY23; up 17% over 2QFY22 – – Decisive Actions to Accelerate... | May 5, 2023